These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11928866)

  • 1. Pigmented (melanotic) neurofibroma. Report of an unusual case with immunohistochemical, ultrastructural and cytogenetic analyses.
    Kuhnen C; Herter P; Soimaru C; Homann HH; Johnen G
    Pathol Res Pract; 2002; 198(2):125-31. PubMed ID: 11928866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor.
    Motoi T; Ishida T; Kawato A; Motoi N; Fukayama M
    Hum Pathol; 2005 Aug; 36(8):871-7. PubMed ID: 16112003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanotic neurofibromas. A report of two cases.
    Deshpande RB; Chitale AA
    Indian J Cancer; 1987 Mar; 24(1):53-61. PubMed ID: 3123365
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
    Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
    Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous epithelioid melanocytic neurofibroma arising in a patient with neurofibromatosis-1.
    Novoa RA; Kovarik CL; Low DW; Argenyi Z
    J Cutan Pathol; 2014 May; 41(5):457-61. PubMed ID: 24472086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients.
    Fetsch JF; Michal M; Miettinen M
    Am J Surg Pathol; 2000 Mar; 24(3):331-43. PubMed ID: 10716146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic support for early malignant change in a diffuse neurofibroma not associated with neurofibromatosis.
    Molenaar WM; Dijkhuizen T; van Echten J; Hoekstra HJ; van den Berg E
    Cancer Genet Cytogenet; 1997 Aug; 97(1):70-2. PubMed ID: 9242221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Melanotic neurofibroma, clinical and histopathologic diagnosis. Case report].
    Zbranca A; Stefan R; Grigorovici M; Cherciu M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):595-8. PubMed ID: 15832981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.
    Peltonen J; Jaakkola S; Lebwohl M; Renvall S; Risteli L; Virtanen I; Uitto J
    Lab Invest; 1988 Dec; 59(6):760-71. PubMed ID: 2462129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melanotic neurofibroma].
    Sibon C; Chrétien-Marquet B; Brousse N; Fraitag S
    Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):583-7. PubMed ID: 15318143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigmented renal clear cell carcinoma with melanocytic differentiation.
    Lei JY; Middleton LP; Guo XD; Duray PH; McWilliams G; Linehan WM; Merino MJ
    Hum Pathol; 2001 Feb; 32(2):233-6. PubMed ID: 11230713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant plexiform neurofibroma in a patient with neurofibromatosis type I.
    Rallis E; Ragiadakou D
    Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental?
    Pongpudpunth M; Bhawan J; Al-Natour SH; Mahalingam M
    Am J Dermatopathol; 2010 Aug; 32(6):574-7. PubMed ID: 20520523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The normal and neoplastic perineurium: a review.
    Piña-Oviedo S; Ortiz-Hidalgo C
    Adv Anat Pathol; 2008 May; 15(3):147-64. PubMed ID: 18434767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis: challenges for applied cellular and molecular biology.
    Riccardi VM
    Lab Invest; 1988 Dec; 59(6):726-8. PubMed ID: 3143861
    [No Abstract]   [Full Text] [Related]  

  • 20. Perineurial cell differentiation in neurofibromas. Report of eight cases including a case with composite perineurioma-neurofibroma features.
    Zamecnik M; Michal M
    Pathol Res Pract; 2001; 197(8):537-44. PubMed ID: 11518046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.